NCT02561338View on ClinicalTrials.gov

A Multi-center 12-week Study of HMS5552 in T2DM

PHASE2CompletedINTERVENTIONAL
Enrollment

258

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

HMS5552

75mgQD

DRUG

HMS5552

100mgQD

DRUG

HMS5552

50mgBID

DRUG

HMS5552

75mgBID

OTHER

Placebo

QD/BID

Trial Locations (1)

Unknown

Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School, Nanjing

Sponsors
All Listed Sponsors
collaborator

Tigermed Consulting Co., Ltd

INDUSTRY

lead

Hua Medicine Limited

INDUSTRY

NCT02561338 - A Multi-center 12-week Study of HMS5552 in T2DM | Biotech Hunter | Biotech Hunter